Integrin Alpha-Beta3 Receptor (Vitronectin Receptor) as a Drug Target and Biomarker

Target Name: Integrin alphavbeta3 (vitronectin) receptor

NCBI ID: P5755

Integrin alphavbeta3 (vitronectin) receptor

Other Name(s): Vitronectin receptor | alphavbeta3 Receptor | Integrin alphavbeta3

Integrin Alpha-Beta3 Receptor (Vitronectin Receptor) as a Drug Target and Biomarker

Introduction

The Integrin Alpha-Beta3 receptor (Vitronectin Receptor), also known as CD73, is a transmembrane protein that plays a crucial role in cell-cell adhesion, migration, and invasion. It is a member of the integrin family, which is known for its role in cell-cell adhesion and migration, including the regulation of cell growth, differentiation, and survival. The Alpha-Beta3 receptor is expressed in various tissues and cell types, including epithelial cells, endothelial cells, pericytes, and immune cells.

The Alpha-Beta3 receptor is involved in many physiological processes, including cell migration, cell adhesion, and tissue repair and regeneration. It is a potential drug target and biomarker due to its unique mechanism of action and its involvement in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Drug Targeting

The Alpha-Beta3 receptor is a potential drug target due to its unique mechanism of action and its involvement in various diseases. One of the main reasons for its potential as a drug target is its role in cell-cell adhesion and migration. The receptor is known to regulate the formation and maintenance of tight junctions, which are a type of cell-cell adhesion that is critical for various physiological processes, including embryonic development, tissue repair and regeneration, and cancer progression.

In addition to its role in cell-cell adhesion, the Alpha-Beta3 receptor is also involved in the regulation of cell migration and invasion. Alpha-Beta3 receptor has been shown to play a role in the regulation of cell migration and the ability of cancer. cells to invade surrounding tissues.

Biomarker

The Alpha-Beta3 receptor is also a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. One of the main reasons for its potential as a biomarker is its expression in various tissues and cell types, including cancer cells, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target and biomarker, the Alpha-Beta3 receptor is also an attractive target due to its unique mechanism of action and its involvement in various physiological processes.

Conclusion

The Alpha-Beta3 receptor is a transmembrane protein that plays a crucial role in cell-cell adhesion, migration, and invasion. It is a potential drug target and biomarker due to its unique mechanism of action and its involvement in various diseases. Further research is needed to fully understand the Alpha-Beta3 receptor and its potential as a drug target and biomarker.

Protein Name: Integrin Alphavbeta3 (vitronectin) Receptor

The "Integrin alphavbeta3 (vitronectin) receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Integrin alphavbeta3 (vitronectin) receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets